Background/Aims: This study aimed to investigate the effect of Nell-1 on the osteogenic behaviors of pre-osteoblasts on titanium (Ti) surfaces and to identify the underlying signaling pathway. Methods: Nell-1 at different concentrations was added to culture medium to stimulate MC3T3-E1 subclone 14 on Ti surfaces. A CCK-8 colorimetric assay was used to detect cell proliferation. Alkaline phosphatase activity (ALP) assay and enzyme-linked immunosorbent assay (ELISA) were used to evaluate ALP activity and the osteocalcin (OCN) secretion, respectively. Indicators of osteoblastic differentiation were assessed using real-time polymerase chain reaction analysis (RT-PCR). Western blot (WB) assay was used to analyze the expression changes of the osteogenic proteins and the mitogen-activated protein kinase (MAPK) pathway. Results: Nell-1 significantly increased the osteogenic gene and protein expression levels of ALP, OCN, Runx2, osteoprotegerin (OPG), collagen type I (Col-I), and Osterix (Osx) in pre-osteoblasts on Ti surfaces. The optimal concentration of Nell-1 was 100 ng/ ml. In addition, Nell-1 activated ERK and JNK, but not P38, in MC3T3-E1 cells on the Ti surface. Except for ALP and Col-I, the promotive effects of Nell-1 on the expression of osteogenic markers were suppressed by ERK inhibitor U0126. Conclusion: Certain concentrations of Nell-1 can promote the osteogenic differentiation of pre-osteoblasts on Ti surfaces by activating the MAPK/ERK signaling pathway.
Nell-1 Enhances Osteogenic Differentiation of Pre-Osteoblasts on Titanium Surfaces via the MAPK-ERK Signaling Pathway
Mei-jie Shen Inhibition of the MAPK/ERK signaling pathway U0126, an ERK/MAPK inhibitor, was purchased from MedChem Express (MCE, USA). MC3T3-E1 preosteoblasts were pre-incubated with U0126 at a concentration of 5 µM for 1 h and then incubated in basal medium or differentiation medium with the inhibitor for 6 to 18 days according to the requirements of each experiment.
Cell viability assay MC3T3-E1 pre-osteoblasts were seeded on the Ti disks in a 12-well plate. After 24 h, the cells were divided into five groups and incubated with Nell-1 at concentrations of 0 ng/m, 1 ng/ml, 10 ng/ml, 100 ng/ ml, or 500 ng/ml at 37°C. On day 1, 3 or 5, the culture medium in each well was replaced with 10% CCK-8 buffer, the cells were incubated for another 2 h and then subjected to a CCK-8 colorimetric assay for cell viability assessment. The solution sample (200 µl) from each well was transferred in triplicate into a 96-well plate, and its absorbance was measured at a wavelength of 450 nm by a spectrophotometer. The mean reading of each triplication was used for the analysis, and the experiment was repeated three times.
Alkaline phosphatase activity assay
Alkaline phosphatase (ALP) activity was measured using an ALP activity assay kit (Wako Pure Chemical Industries, Ltd., 1-2, Doshomachi 3-Chome, Chuo-Ku, Osaka, Japan). The MC3T3-E1 pre-osteoblasts cultured in 6-well plates were lysed with 80 µl of cell lysis reagent (Sigma-Aldrich, St Louis, MO, USA) and then the lysate was normalized for total cellular protein content using a BCA protein assay kit (Thermo, Rockford, IL, USA). After reaction with p-nitrophenol phosphate (pNPP) substrate, the OD values of the standards and samples were measured at a wavelength of 405 nm according to the manufacturer's instructions to evaluate the ALP activity level. The experiment was repeated three times in quadruplicate wells.
Enzyme-linked immunosorbent assay (ELISA) for OCN expression
The supernatant in each well of the 6-well plates was collected and stored in a refrigerator at 80°C prior to OCN quantification. The OCN levels were determined using commercially available mouse-specific ELISA kits (R&D Systems, USA). The absorbance at a wavelength of 450 nm was measured using a microplate reader. The results were normalized according to the total cellular protein content determined with a BCA protein assay kit and expressed as ng/mg protein. 
Western blot (WB) assay
The MC3T3-E1 pre-osteoblasts cultured in 6-well plates to subconfluence were stimulated with Nell-1 at concentrations of 0 g/m, 1 ng/ml, 10 ng/ml, 100 ng/ml, or 500 ng/ml. Cellular proteins were extracted using RIPA lysis buffer (Sigma-Aldrich) and quantified using a BCA protein assay kit. After protein separation on a 10% SDS-PAGE gel, the sample was transferred to a PVDF membrane (Bio-Rad, Hercules, CA, USA). After blocking with 5% fat-free milk, the membrane was incubated overnight at 4°C with the following primary antibodies: osteoprotegerin (Cat.ab9986, Abcam), Collagen I (Cat.ab34710, Abcam), Runx2 (Cat.8486, Cell Signaling), Phospho-ERK1/2 (Cat.4370, Cell Signaling), ERK1/2 (Cat.4695, Cell Signaling), Phospho-SAPK/ JNK (Cat.4668, Cell Signaling), SAPK/JNK (Cat.9252, Cell Signaling), Phospho-P38 (Cat.4511, Cell Signaling), P38 (Cat.8690, Cell Signaling), or GAPDH. Except for anti-Phospho-ERK1/2 antibody, which was used at a dilution of 1:2000, all primary antibodies were used at 1:1000 dilution. The following morning, the membrane was incubated with the corresponding secondary HRP-conjugated antibodies for 1 h at room temperature and then exposed to an ECL reagent (Super Signal, Pierce, Rockford, IL, USA). The signals were viewed and analyzed using the ChemiDicTM XRS+ imaging system (Bio-Rad Laboratories, Hercules, CA, USA), and the band densities were quantified with Image Lab software (BioRad). Each test was repeated at least three times.
Real-time PCR
MC3T3-E1 pre-osteoblasts in 6-well plates were washed three times with PBS and lysed with TRIzol reagent (TriPure Isolation Reagent, Roche Applied Science). Total RNA was extracted according to the manufacturer's protocol. The extracted RNA was quantified with UV spectrophotometry, and only samples with a ratio of absorbance at 260 and 280 nm (the 260/280 ratio) greater than 1.8 were used in the subsequent steps. Total RNA (0.5 μg) was reverse transcribed in duplicate, and another RNA sample incubated without reverse transcriptase was used as the control (noRT control). The PrimeScript RT reagent kit was used for cDNA synthesis, and a MyCycler TM thermocycler (Bio-Rad, USA) was used for polymerase chain reaction (PCR). All primers used are listed in Table 1 . Samples were run in parallel with each primer set in real-time PCR with bio-radiQ SYBR® Green Super Mix. Each step was repeated at least three times.
Statistical analysis
The results were analyzed using SPSS software (SPSS 21, Chicago, IL, USA). The data are presented as means ± SD; at least three independent experiments were performed for each test. Differences between groups were assessed with Student's t-test and one-way analysis of variance. P values < 0.05 were considered statistically significant.
Results

Ti surface characteristics and growth of MC3T3-E1 pre-osteoblasts
The processed Ti surface presented an uneven and rough morphology in SEM images (Fig. 1A) . At 24 h after seeding, MC3T3-E1 cells were attached to the Ti surface and well dispersed. Moreover, the cells developed polygonal membranes and showed the morphological characteristics of pre-osteoblasts (Fig. 1B) . 
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Nell-1 suppressed the proliferation but enhanced the osteogenesis of MC3T3-E1 preosteoblasts on the Ti surface
The proliferation of MC3T3-E1 pre-osteoblasts was assessed with a CCK-8 assay. The proliferation activity of the cells treated with 10, 100 and 500 ng/ml Nell-1 was significantly lower than that of the control group on the Ti surfaces, suggesting that Nell-1 suppressed the proliferation of MC3T3-E1 pre-osteoblasts in a dose-dependent manner (Fig. 2) . Early osteogenesis is characterized by increased ALP activity. In this study, after Nell-1 treatment, the ALP activity of MC3T3-E1 cells attached to the Ti surface increased remarkably from day 4 to day 8 and then decreased between days 8 and 12. In particular, Nell-1 at concentrations of 10 and 100 ng/ml significantly enhanced the ALP activity of the cells. The most prominent change occurred on post-treatment day 8 in the cells treated with 100 ng/ml Nell-1 (P < 0.05) (Fig. 3) . Next, the expression of OCN, an osteogenic marker of later stages of osteogenesis, was tested. The results showed that OCN expression increased from day 6 to day 18 and then declined from day 18 to day 24. On days 12 and 18, OCN expression in the cells treated with 10 and 100 ng/ml Nell-1 was significantly higher than that of the control group in differentiation media (P < 0.05), with the highest expression occurring on day 18 in the 100 ng/ml Nell-1 treatment group (Fig. 4) . Additionally, after 6 days of Nell-1 stimulation, the expression of Runx2, osteoprotegerin (OPG), and collagen type I (Col-I) significantly Fig. 3 . Effect of Nell-1 on the ALP activity of MC3T3-E1 pre-osteoblasts cultured on Ti surfaces. Cells cultured in basal medium or differentiation medium containing different concentrations of Nell-1 (0-500 ng/ml) were monitored for ALP activity. The results at days 4, 8 and 12 showed that ALP activity in the cells was enhanced by Nell-1 and was highest in the 100 ng/ml group on the 8 th day. Data represent the mean ± SD (bars) of three independent experiments; *P<0.05, **P<0.01 compared with the cells cultured in differentiation medium containing 0 ng/ml Nell-1. Fig. 2 . Effect of Nell-1 on the proliferation of MC3T3-E1 pre-osteoblasts cultured on Ti surfaces. Treatment with Nell-1 at all concentrations (0-500 ng/ml) decreased the proliferation of MC3T3-E1 cells on Ti surfaces from day 1 to day 5 in a time-dependent manner. Data represent the mean ± SD (bars) of three independent experiments; *P<0.05, **P<0.01* compared with the 0 ng/ml Nell-1 treatment group (control group).
Fig. 4.
Effect of Nell-1 on osteocalcin expression in MC3T3-E1 pre-osteoblasts cultured on Ti surfaces. Cells cultured in basal medium or differentiation medium containing different concentrations of Nell-1 (0-500 ng/ml) were monitored for OCN expression. The results at days 6, 12, 18, and 24 showed that OCN expression in the cells was enhanced by Nell-1, and expression was highest in the 100 ng/ml group on the 18 th day. Data represent the mean ± SD (bars) of three independent experiments; *P<0.05, **P<0.01 compared with cells cultured in differentiation medium containing 0 ng/ ml Nell-1. increased in cells treated with 10, 100 and 500 ng/ml Nell-1 compared with the control group, with the most prominent increase occurring in the 100 ng/ml Nell-1 treatment group (P <0.01) (Fig. 5) .Consistent with these results, real-time PCR analysis demonstrated that the mRNA expression levels of all the detected osteogenic markers, including ALP, OCN, Runx2, OPG, Col-I and Osterix (Osx), in MC3T3-E1 pre-osteoblasts were upregulated after Nell-1 treatment and were highest in the 100 ng/ml Nell-1 group compared with the control group (Fig. 6) . 
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Nell-1 activated ERK and JNK in MC3T3-E1 pre-osteoblasts on the Ti surface
The activation of ERK, p38, and JNK in MC3T3-E1 cells cultured in serum-free α-MEM on the Ti surface were examined after 1 h of Nell-1 stimulation. WB assays showed that while no remarkable change in P38 phosphorylation was detected, the phosphorylation of JNK and ERK in MC3T3-E1 cells was significantly enhanced by Nell-1, particularly by 100 ng/ml Nell-1, compared with the control groups (P < 0.05) (Fig. 7) .
U0126 inhibited Nell-1-promoted osteoblast differentiation
To further verify the relationship between Nell-1 and ERK activation and elucidate the role of Nell-1 in promoting ALP activity in pre-osteoblasts, U0126 (5 μM), an ERK inhibitor, was used to pretreat the MC3T3-E1 cells 8 days before treatment with Nell-1 at the concentration of 100 ng/ml. The results showed that ALP activity in the cells that were pretreated with U0126 and then treated with 100 ng/ml Nell-1 increased compared to the unpretreated control cells (Fig. 8B) . However, the MC3T3-E1 cells treated with U0126 alone also showed significantly upregulated ALP activity; consequently, the evidence regarding Nell-1 at concentrations of 0-500 ng/ ml for six days. Western blot analysis of p-JNK and p-ERK shows that Nell-1 enhanced the phosphorylation of JNK (B) and ERK (C) but suppressed P38 phosphorylation. GAPDH was used as an internal control, and the expression levels of phosphorylated JNK, ERK and P38 were normalized to those of total JNK, ERK and P38, respectively. Data represent the mean ± SD (bars) of three independent experiments; *P<0.05, **P<0.01 compared with cells cultured in differentiation medium containing 0 ng/ml Nell-1.
Fig. 8. A: Promotive effect of U0126
on Nell-1-induced changed in the ALP activity of MC3T3-E1 pre-osteoblasts on Ti surfaces. Cells were cultured in basal medium or differentiation medium containing 100 ng/ml Nell-1 with or without the addition of 5 μM U0126 on day 8. B: Suppression of Nell-1-enhanced OCN expression in MC3T3-E1 pre-osteoblasts on Ti surfaces. Cells were cultured in basal medium or differentiation medium containing 100 ng/ml Nell-1 with or without the addition of 5 μM U0126 on day 18. Data represent the mean ± SD (bars) of three independent experiments; *P<0.05, **P<0.01 compared with cells cultured in differentiation medium containing 0 ng/ml Nell-1. 
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whether U0126 can inhibit Nell-1-promoted ALP activity remained inconclusive (Fig. 8A) . The effect of U0126 pretreatment on OCN expression in MC3T3-E1 cells stimulated by Nell-1 for 18 days was then evaluated. Nell-1 significantly increased OCN expression, and U0126 effectively inhibited this effect, suggesting that U0126 can suppress Nell-1-promoted OCN expression by inhibiting ERK1/2 (Fig. 8B) .For the differentiation markers Runx2, OPG and Col-Ion, WB assays revealed an upregulation of their expression levels in the MC3T3-E1 cells treated with Nell-1 for 6 days, and the upregulation of all markers except Col-I was suppressed by U0126 pretreatment. Similar to the findings regarding ALP activity, Col-I upregulation induced by Nell-I was further enhanced by U0126 (Fig. 9) .
Finally, the mRNA expression of osteogenic markers in MC3T3-E1 cells treated with Nell-1 for 6 days were tested. Consistent with the WB results, the mRNA expression of all these markers was upregulated after Nell-1 treatment, and except for ALP and Col-I, transcriptional promotion by Nell-1 was inhibited by U0126 (Fig. 10) .
Discussion
Titanium implants have been widely used in clinical settings due to their excellent biological properties and reliable and predictable performance [27, 28] . An ideal dental implant surface enhances the abilities of osteoblasts to secrete matrix proteins and deposit bone mineral for osteogenesis and facilitates osteointegration to withstand occlusal loading, which is pivotal for the implant's success [3] . In addition, a number of exogenous growth factors that can promote the early adhesion and differentiation of osteoblasts have gained increasing attention in the field of oral implantation [29] . Primary considerations in the development of dental implants include optimizing cell-tissue interactions, enhancing the bone response to the endosseous implant, and promoting the favorable behavior of bone tissue at the interface zone. For this purpose, pure Ti plates that have been polished, sandblasted and passivated can serve as ideal dental implants. B Groessner-Schreiber et al. proved that that porous or rough Ti implant surfaces may act as "natural" substrata that allow bone tissue to grow in direct contact with an implant and thereby strengthen clinical implant fixation [30] . In this study, scanning electron microscopy (SEM) showed that the Ti surface was rough and uneven and that pre-osteoblasts attached to the Ti surface for 24 h were completely spread out.
Nell-1 is osteochondral specific for inducing premature suture closure in human craniosynostosis and chondrogenic or osteoblastic differentiation [7, 8, [31] [32] [33] . When adenovirus-mediated (Ad-) Nell-1 and Ad-BMP2 were transferred to bone marrow stromal cells (BMSCs) from adult goats or injected into the intermuscular spaces of nude mice, Nell-1 had a promotive effect on the osteogenic differentiation of BMSCs similar to that of bone morphogenetic protein-2 (BMP2) [34] . In addition, the co-expression of Nell-1 and apoptosisrelated protein 3 (APR3) enhanced OCN and BSP expression and matrix mineralization when Nell-1 and APR3 were assembled in the nuclear envelope of the human osteoblast cell lines Saos2 and U2OS [35] . IN particular, MC3T3-E1 pre-osteoblasts carrying the Nell-1 gene that overexpresses Nell-1 protein also have a higher expression of osteogenic markers compared with normal cells [16] . Matrix mineralization is enhanced in the MC3T3-E1 cells cultured in the presence of rhNell-1 or rhBMP-2 [36] . However, whether the addition of Nell-1 to culture medium can promote the osteogenic differentiation of pre-osteoblasts on the surface of Ti disks remains to be clarified.
Osteoblast differentiation includes two main processes: osteogenic commitment and osteogenic differentiation [37] . Osteogenic commitment is defined by the upregulation of a key transcription factor, Runx2 [37] , while osteogenic differentiation is characterized by the expression of specific osteogenic proteins and transcription factors, such as ALP, OCN, COl-I, osteoprotegerin (OPG) and Osterix (Osx) [38] [39] [40] [41] [42] [43] [44] . In this study, ALP activity and OCN expression increased significantly in the Nell-1-treated cells on Ti surfaces compared with cells cultured in basal medium or Nell-1-free differentiation medium. The highest ALP activity and OCN expression were observed in the 100 ng/ml Nell-1 groups. The gene expressions of ALP and OCN were also improved in these groups. In addition, the expression of Runx2, Col-I, OPG and Osx was augmented by Nell-1 at both the gene and protein levels. Consistently, the expression of these osteogenic proteins and genes was highest in cells treated with Nell-1 at the concentration of 100 ng/ml. However, this study found that cell proliferation in the Nell-1-treated groups decreased over time compared with the control group, suggesting Nell-1 inhibited the proliferation of MC3T3-E1 cells on Ti surfaces. Nell-1 positively promoted osteogenesis but negatively affected the proliferation of pre-osteoblasts, indicating that Nell-1 has a stronger and more specific effect for eliciting osteoblast differentiation.
Osteogenic differentiation is a complex process involving numerous signaling cascades. Most of the exogenous growth factors involved in osteogenesis, such as BMP-2 and FGF, act on osteoblasts by binding to their cell-surface receptors to activate intracellular signaling pathways [45] . MAPKs, which are a group of serine/threonine-specific protein kinases expressed in all cell types, regulate various cellular processes, including proliferation, differentiation, migration, survival and gene expression [46] . The MAPK pathway is the most active pathway, and it can be activated by various growth factors [21] . The findings that MAPK induces the phosphorylation and stabilization of Runx2 suggest that MAPK-ERK signaling might have a positive effect on osteogenesis [22] [23] [24] . Therefore, to further elucidate the mechanisms underlying the effects of Nell-1, the MAPK-ERK signaling pathway was comprehensively investigated in the present study. The results showed that Nell-1 effectively activated the ERK and JNK pathways rather than the P38 pathway in pre-osteoblasts on Ti surfaces. Nakamura Y et al. found that Nell-1 mediated cell adhesion by binding to integrin receptors to activate ERK in MC3T3-E1 cells [47] , confirming that Nell-1 can activate the ERK pathway in pre-osteoblasts. Interestingly, the selective activation of different MAPK pathways by Nell-1 depends on cell type [26] . Nell-1 effectively activates ERK in Saos-2 cells and all three major MAPKs in RFC cells, but activates ERK and JNK transiently in C3H10T1/2 cells and only JNK in C2C12 cells [14, 26] . In addition, compared with BMP2, Nell-1 does not affect the Smadl/5/8 pathway in any cell type [26] . It is noteworthy that OPN production could be reduced by the siRNA-mediated degradation of Ras through the inhibition of the ERK pathway [26] . Moreover, the JNK inhibitor SP600125 suppresses Nell-1-induced mineralization and intracellular phosphate accumulation in Saos-2 cells, while ERK1/2 and P38 inhibitors have no effect [48] . In this study, the expression of a series of osteogenic proteins and genes in pre-osteoblasts was significantly decreased by co-treatment with the ERK inhibitor U0126 and Nell-1. Nell-1 elevated the expression levels of OCN, Runx2, OPG and Osx, and its promotive effect could be reversed by U0126. The results suggest that the MAPK/ERK signaling pathways may be involved in the Nell-1-induced osteogenic differentiation of pre-osteoblasts on Ti surfaces.
Conversely, the results showed that ALP activity and the protein and gene expressions of Col-I were much higher in the cells treated with ERK inhibitor than in untreated cells. We speculated that U0126 may cause other effects in addition to suppressing the ERK signaling pathway, leading to an increase in ALP and Col-I. Previous research found that U0126 can activate the phosphorylation of P38 in BMSCs and increase ALP activity [49] . Consistently, this study confirmed that the expression of p-P38 in MC3T3-E1 cells could be up-regulated by U0126 treatment for 1 h (Fig. 11) . P38 kinase is essential for the regulation of ALP expression during osteogenic differentiation [50] . Moreover, previous research found that p38 may be involved in the control of type I collagen expression [50] . Thus, it is very possible that U0126 may activate P38 or other pathways, leading to the upregulation of ALP and Col-I. Nevertheless, we could not rule out the possibility that the inhibition of a signaling pathway will lead to the inhibition or activation of other pathways due to the complex relationships of these pathways, and this possibility needs to be further explored. 
Conclusion
The results suggest that Nell-1 promoted the osteogenic differentiation of pre-osteoblasts on a Ti surface. One of the mechanisms of Nell-1-mediated osteoblastic differentiation may be the activation of MAPK-ERK signaling, but the exact regulatory mechanisms need to be further explored. Nell-1 exerted a positive effect on osteogenic differentiation, which makes it a good candidate growth factor for clinical application to promote the osteointegration of dental implants. Fig. 11 . Promotive effect of U0126 on P38 phosphorylation in MC3T3-E1 pre-osteoblasts. Cells on Ti surfaces were treated with U0126 (0-10 μM) for 1 h. A: Representative Western blots of p-P38 and P38. B: Western blot analysis of p-P38 expression. The expression level of phosphorylated P38 was normalized to that of total P38. Data represent the mean ± SD (bars) of three independent experiments; *P<0.05, **P<0.01* compared with cells cultured in differentiation medium containing 0 ng/ml U0126.
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